Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Clopidogrel and K-877 in Healthy Volunteers
NCT02922465Phase 1Completed
- Start
- Sep 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pemafibrate in dyslipidemia. Primary endpoints: Maximum Plasma Concentration up to 72 hours and Area Under the Curve up to 72 hours. Started Sep 2016; status: completed.
02
Drugs
pemafibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02922465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922465.